Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
Nature Medicine 23(6) (2017)
Guang‐Nian Zhao; Peng Zhang; Jun Gong; Xiao‐Jing Zhang; Pi‐Xiao Wang; Miao Yin; Zhou Jiang; Lijun Shen; Yan‐Xiao Ji; Jingjing Tong; Yutao Wang; Qiao-Fang Wei; Yong Wang; Xue‐Yong Zhu; Xin Zhang; Jing Fang; Qingguo Xie; Zhi‐Gang She; Zhihua Wang; Zan Huang; Hongliang Li
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
The Journal of Infectious Diseases 224(2) (2020)
Jie Li; Hwai‐I Yang; Ming‐Lun Yeh; Michael Huan Le; An K. Le; Yee Hui Yeo; Chia‐Yen Dai; Scott Douglas Barnett; Jian Q. Zhang; Jee‐Fu Huang; Huy Ngoc Trinh; Christopher Wong; Clifford C. Wong; Joseph K. Hoang; Ramsey C Cheung; Ming‐Lung Yu; Mindie H. Nguyen
Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B
Alimentary Pharmacology & Therapeutics 54(9) (2021)
Qi Zheng; Biyao Zou; Yuankai Wu; Yee Hui Yeo; Huizhen Wu; Christopher Donald Stave; Ramsey C Cheung; Mindie H. Nguyen
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
The Journal of Infectious Diseases 224(11) (2021)
Yao‐Chun Hsu; Ming‐Lun Yeh; Grace Lai‐Hung Wong; Chien‐Hung Chen; Cheng‐Yuan Peng; Marı́a Buti; Masaru Enomoto; Qing Xie; Huy Ngoc Trinh; Carmen Monica Preda; Li Liu; Ka Shing Cheung; Yee Hui Yeo; Joseph K. Hoang; Chung‐Feng Huang; Mar Riveiro‐Barciela; Ritsuzo Kozuka; Doina Istrătescu; Pei‐Chien Tsai; Elena Vargas‐Accarino; Dong-Hyun Lee; Jia‐Ling Wu; Jee Fu Huang; Chia‐Yen Dai; Ramsey C Cheung; Wan‐Long Chuang; Man‐Fung Yuen; Vincent Wai‐Sun Wong; Ming‐Lung Yu; Mindie H. Nguyen
Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water
Laboratory Investigation 98(9) (2018)
Xuejing Liu; Xue-Jing Liu; Chang Liu; C Liu; Chen Niu; Xiu-Ping Liu; Xiuping Liu; Jian Wu
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
Clinical and Molecular Hepatology 29(3) (2023)
Yu Jun Wong; Vy H. Nguyen; Hwai‐I Yang; Jie Li; Michael Huan Le; Wan‐Jung Wu; Nicole Xinrong Han; Khi Yung Fong; Elizebeth Chen; Hong-Nei Wong; Fajuan Rui; Xiaoming Xu; Qi Chao Xue; Xin Yu Hu; Wei Qiang Leow; George Boon‐Bee Goh; Ramsey C Cheung; Grace Lai‐Hung Wong; Vincent Wai‐Sun Wong; Ming‐Whei Yu; Mindie H. Nguyen
Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?
Liver International 40(3) (2020)
Jianbin Zhang; Shuang‐Zhe Lin; Daixi Jiang; Mengting Li; Yuanwen Chen; Jun Li; Jian‐Gao Fan
NAFLD and HBV interplay - related mechanisms underlying liver disease progression
Frontiers in Immunology 13 (2022)
Evanthia Tourkochristou; Stelios F. Assimakopoulos; Konstantinos Thomopoulos; Markos N. Marangos; Christos K Triantos
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
Clinical and Molecular Hepatology 31(Suppl) (2024)
Saisai Zhang; Lung‐Yi Mak; Man‐Fung Yuen; Wai‐Kay Seto
Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study
Virology Journal 21(1) (2024)
Sitong Yi; Guanghui Ren; Ying Zhu; Qingwei Cong
The outcomes and mechanisms of chronic hepatitis B complicated by metabolic dysfunction-associated steatotic liver disease
Hepatobiliary & pancreatic diseases international 24(5) (2025)
Mao-Ping Li; Kaizhong Luo
Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview
International Journal of Molecular Sciences 22(19) (2021)
Mohammad Enamul Hoque Kayesh; Michinori Kohara; Kyoko Tsukiyama–Kohara
Dietary Fatty Acids Amplify Inflammatory Responses to Infection through p38 MAPK Signaling
American Journal of Respiratory Cell and Molecular Biology 60(5) (2019)
Sandra Rutting; Razia Zakarya; Jack Bozier; Dikaia Xenaki; Jay Christopher Horvat; Lisa G. Wood; Philip M. Hansbro; Brian Gregory George Oliver
The link between TLR7 signaling and hepatitis B virus infection
Life Sciences 158 (2016)
Zahra Sepehri; Zohre Kiani; Seyed Moayed Alavian; Mohammad Kazemi Arababadi; Derek D. Kennedy
Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress
Molecular and Cellular Biochemistry 477(11) (2021)
Qichuang Liu; Mao-Yuan Mu; Huan Chen; Guoyuan Zhang; Yanqing Yang; Jun Chu; Ying Li; Fangwan Yang; Shide Lin
Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections
Expert Opinion on Drug Discovery 13(7) (2018)
Keye Du; Jia Liu; Ruth Broering; Xiaoyong Zhang; Dongliang Yang; Ulf Dittmer; Mengji Lu
The Effects of Hepatic Steatosis on the Natural History of HBV Infection
Clinics in Liver Disease 23(3) (2019)
Idrees Suliman; Noha Abdelgelil; Farah Kassamali; Tarek Hassanein
Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink
Pathogens 13(1) (2024)
Cornelius James Fernandez; Mohammed Khalid Alkhalifah; Hafsa Afzar; Joseph M Pappachan
Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
Heliyon 9(1) (2023)
Lili Liu; Hong Li; Yang Zhang; Jing Zhang; Zhenhuan Cao
Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
Brazilian Journal of Microbiology 54(2) (2023)
Sanjit Boora; Vikrant Sharma; Sulochana Kaushik; Sulochana Kaushik; Ajoy Varma Bhupatiraju; Sandeep Singh; Samander Kaushik; Samander Kaushik
Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease
Chinese Medical Journal 135(14) (2022)
Xin Tong; Yu Song; Shengxia Yin; Jian Wang; Rui Huang; Chao Wu; Junping Shi; Jie Li
Impact of Metabolic Dysfunction-Associated Fatty Liver Disease of Varying Severity on Antiviral Treatment Outcomes and Clinical Prognosis in Patients with Chronic Hepatitis B: A Systematic Review and Meta-analysis
Infectious Diseases and Therapy 14(8) (2025)
Qianqian Zhu; Chang Su; Mingdan Li; Yali Xu; Qian Liu; Ying Zhang; Xinyi Zhang; Qiuxiang Li; Huajun Wang; Yawen Luo; Ping Yang
Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study
Journal of Clinical Medicine 13(18) (2024)
Fadi Abu Baker; Abdel‐Rauf Zeina; Randa Taher; Saif Abu Mouch; Ariel Israel
Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
Virology Journal 22(1) (2025)
Guanghui Ren; Kaining Jia; Yin Shi; Yunpeng Guan; Qingwei Cong; Ying Zhu
Unveiling low level viremia in chronic hepatitis B: challenges and new horizons
Frontiers in Cellular and Infection Microbiology 15 (2025)
Bingqing Wang; Tian Zeng; Wen Yin; Chengrui Ren; Yuting Chen; Liqin Qian; Peng Huang; Chuanlong Zhu; Ming Yue
Impairment of Rab7-dependent STING degradation hampers HBV replication but accelerates disease progression in chronic hepatitis B comorbid with MASLD
Gut (2026)
Wenhui Wu; Qiang Gao; Suping Hai; Xitang Li; Binghui Yu; Junjian Hu; Feiyang Xu; Xizhe Zheng; Yuanyuan Wang; Awang Danzeng; Bin‐hao Zhang; Qin Ning; Xiaojing Wang
Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B
World Journal of Hepatology 14(4) (2022)
Yuge Zhou; Ning Tian; Weining Xie
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
Journal of Clinical and Translational Hepatology 000(000) (2022)
Siyu Zhang; Xiaoxiao Zhang; Huiming Jin; Yao Dou; Lu Li; Xiwei Yuan; Chen Dong; Mengmeng Hou; Yuemin Nan; Jia Shang
Sac1 phosphatidylinositol 4‐phosphate phosphatase is a novel host cell factor regulating hepatitis B virus particles assembly and release
FEBS Journal 289(23) (2022)
Mirela‐Andreea Popescu; David Sebastian Patriche; Mihaela‐Olivia Dobrica; Ana‐Maria Pantazica; Petruta‐Ramona Flintoaca; Yves Rouillé; Costin-Ioan Popescu; Norica Branza‐Nichita
Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease
Journal of Viral Hepatitis 31(10) (2024)
Nishi H. Patel; Aaron Lucko; Alicia Vachon; Karen Elizabeth Doucette; Alnoor S. Ramji; Laura K. Sycuro; Trushar R. Patel; Kris Chadee; Maitreyi Raman; Guido van Marle; Carla Osiowy; Carla S. Coffin
Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B
Journal of Gastroenterology and Hepatology 40(9) (2025)
Tyng‐Yuan Jang; Chih‐Wen Wang; Po‐Cheng Liang; Yu‐Ju Wei; Ming‐Lun Yeh; Yi‐Hung Lin; Chao‐Kuan Huang; Chao‐Kuan Huang; Pei‐Chien Tsai; Yu‐Min Ko; Yi‐Shan Tsai; Kuan‐Yu Chen; Ching‐Chih Lin; Zu‐Yau Lin; Jee‐Fu Huang; Chia‐Yen Dai; Chung‐Feng Huang; Chung‐Feng Huang; Wan‐Long Chuang; Ming‐Lung Yu
Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis
PLoS ONE 11(5) (2016)
Marwa K. Ibrahim; Ghada Maher Salum; Noha G. Bader El Din; Reham Mohammed Dawood; Ahmed Barakat; Ahmed M. Khairy; Mostafa K. El Awady
Obesity management for the hepatologist—What to do, how to do it and why?
Hepatology 81(5) (2023)
Kymberly D. S. Watt; Sonali Paul; Mohammad Qasim Khan; Mohammad Shadab Siddiqui; Jenny Lam; Tayyab S. Diwan; Michael Camilleri
Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study
World Journal of Gastroenterology 22(47) (2016)
Dipanwita Das; Neelakshi Sarkar; Isha Sengupta; Ananya Pal; Debraj Saha; Manikankana Bandopadhyay; Chandrima Das; Jimmy Narayan; Shivram Prasad Singh; Runu Chakravarty
Evaluation on Heterogeneity of Fatty Liver in Rats: A Multiparameter Quantitative Analysis by Dual Energy CT
Academic Radiology 26(5) (2018)
Qiuting Cao; Shufan Shang; Xinjun Han; Di Cao; Liqin Zhao
Identification and characterization of SEC24D as a susceptibility gene for hepatitis B virus infection
Scientific Reports 9(1) (2019)
Xianzhong Jiang; Bin Zhang; Junsheng Zhao; Yi Xu; Haijun Han; Kunkai Su; Jingjing Tao; Rongli Fan; Xinyi Zhao; Lanjuan Li; Ming D. Li
Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index
BMJ Open Gastroenterology 7(1) (2020)
Ta-Wei Liu; Chung‐Feng Huang; Ming‐Lun Yeh; Pei‐Chien Tsai; Tyng‐Yuan Jang; Jee‐Fu Huang; Chia‐Yen Dai; Wan‐Long Chuang; Ming‐Lung Yu
Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis
BMC Pulmonary Medicine 22(1) (2022)
Takahito Suzuki; Masato Karayama; Yusuke Inoue; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda
Liver enzymes and fibrosis markers in patients with non-alcoholic fatty liver disease and concomitant chronic viral hepatitis
Canadian Liver Journal 4(3) (2020)
Micah Grubert Van Iderstine; Julia Uhanova; Gerald Yosel Minuk
Effects of Acalypha indica L. Extract on Inflammatory Response in The Pathogenesis of Nonalcoholic Fatty Liver Disease: An Overview of TLR9, NFκB and TNFα Expression in Hepatocytes and Macrophages of Sprague-Dawley Rats
Pharmacognosy Journal 14(6) (2023)
Novianti Supriatna; Nurjati Chairani Siregar; Erni Hernawati Purwaningsih; Linda Erlina
The Association Between Weight Loss and Hepatitis B Surface Antigen Seroclearence in Chronic Hepatitis B Patients
Hepatitis Monthly 24(1) (2024)
Nazan Tuna; Aylin Çalıca Utku; Aslı Vatan; Aziz Öğütlü; Ertuğrul Güçlü; Oğuz Karabay
Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study
Liver Cancer 14(1) (2024)
Chi‐Ling Chen; Wei‐Shiung Yang; Hwai‐I Yang; Chuen-Fei Chen; Liyu Wang; Sheng‐Nan Lu; Jia‐Horng Kao; Pei‐Jer Chen; Chien‐Jen Chen
Intrinsic Immune Response of HBV/HDV-Infected Cells and Corresponding Innate (Like) Immune Cell Activation
Livers 4(4) (2024)
Christopher Groth; Svea Wupper; Gnimah Eva Gnouamozi; Katrin Böttcher; Adelheid Cerwenka
Tissue-resident memory CD8+T cells might enhance HBV DNA clearance in CHB patients with MASLD complication and normal ALT via the CCL-CCR pathways
Frontiers in Cellular and Infection Microbiology 15 (2025)
Chao Cai; Wen-Xuan Shang; Si-Jie Zheng; Chen Chen; Ke Xu; Chen Lu; Yajie Wang; Yu-Qun Wang; Ruicong Chen; Yijing Cai; Hui-Fang Zhang; Chen Yu Huang; Ji Lin; Bangguo Zhou; Xiuli Lin; Lei Zhang; Mingqin Lu
Steatosis paradox: Unraveling pathways of suppressive effect of hepatic steatosis on hepatitis B virus
Biomedical Journal 49(3) (2026)
Shang‐Chin Huang; Jia‐Horng Kao
Metabolic dysfunction-associated fatty liver disease in chronic hepatitis B: dual effects on hepatocarcinogenesis and evolving strategies for risk prediction
Frontiers in Immunology 17 (2026)
Huihui Tao; Yuxin Duan; Guoyang Yu; Wei Yan; Jianhua Yin
Impact of nonalcoholic fatty liver disease on the response to pegylated interferon-α therapy in patients with chronic hepatitis B
Microbiology Spectrum 14(8) (2026)
Huiqing Liang; Y D Xie; Yan Dai; Xiaorong Yang; Xiaoting Zheng; JiaEn Yang; Liu Y; Chuncheng Wu; S Y Chen; Manying Zhang; Hongli Zhuang; Li Li; Shaodong Chen
Basic Research on Toll-Like Receptors in Metabolism-Related Fatty Liver Disease
Advances in Clinical Medicine 13(06) (2023)
晓阳 王
Metabolic dysfunction-associated steatotic liver disease in chronic hepatitis B patients: risks of severe liver disease and cardiovascular disease
Frontiers in Cellular and Infection Microbiology 16 (2026)
Ningxin Zhang; Zhongwei Xu; Fei Lin; Haozhi Fan; Dehong Zhou; Shiqiu Zheng; Peng Jin; Huiquan Gu; Chengxiao Yu; Longfeng Jiang
Alcohol involvement may modify the association between previous hepatitis B virus infection and hepatocellular carcinoma risk in steatotic liver disease
Journal of Gastroenterology 61(10) (2026)
Naohiro Yasuura; Goki Suda; Masatsugu Ohara; Daisuke Yokoyama; Takatsugu Tanaka; Akimitsu Meno; Takuya Sho; Risako Kohya; Ruixin Deng; Qingjie Fu; Zijian Yang; Osamu Maehara; Shunsuke Ohnishi; Takashi Kitagataya; Naoki Kawagishi; Masato Nakai; Tatsuhiko Kakisaka; Akinobu Taketomi; Naoya Sakamoto
Lipid metabolism remodeling the immunological landscape of hepatocellular carcinoma: From mechanisms to therapeutics
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1881(5) (2026)
Kaitong Mai; Junqing Jiang; Xianglong Ma; Wenjie Huang; Limin Xia
The “viral–metabolic” interaction mechanisms and management challenges in chronic hepatitis B combined with metabolic dysfunction-associated fatty liver disease: from clinical evidence to an integrated multidisciplinary framework
Frontiers in Immunology 17 (2026)
Qianqian Zhu; Chengde Su; 姚巧巧; Ting Yang; Yali Xu; MingDan Li; Qian Liu; YaWen Luo; Ping Yang
MAFLD is linked to lower HBV DNA levels in chronic hepatitis B: clinical and transcriptomic insights
Frontiers in Medicine 13 (2026)
Xiaoyun Gao; Xuan Du